NASDAQ : NMTC
NeuroOne Medical Technologies Corporation — Financial statements
Healthcare · Medical Devices · United States
Last price 0.9272 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.44M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
NeuroOne Medical Technologies Corporation (NMTC) reported revenue of 12.47M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 12.47M | 12.10M | 3.45M | 3.41M | 2.12M | 242.96K |
| Cost of Revenue | 9.60M | 8.94M | 7.44M | 8.44M | 5.17M | 4.20M |
| Gross Profit | 2.87M | 3.16M | -3.99M | -5.03M | -3.05M | -3.96M |
| Selling, General & Admin | 7.77M | 7.38M | 7.90M | 6.93M | 6.98M | 6.26M |
| Operating Expenses | 10.77M | 7.38M | 7.90M | 6.93M | 6.98M | 6.26M |
| Operating Income | -7.90M | -4.23M | -11.89M | -11.96M | -10.03M | -10.22M |
| Interest Expense | -200.00K | -100.00K | -3.05K | |||
| Interest & Investment Income | 200.00K | |||||
| Other Non Operating Income (Expenses) | 933.67K | 821.10K | -330.90K | -72.24K | 31.15K | -10.24K |
| EBT Excluding Unusual Items | -6.97M | -3.61M | -12.32M | -11.83M | -10.00M | -10.23M |
| Gain (Loss) on Sale of Assets | -32.00K | |||||
| Legal Settlements | 200.00K | |||||
| Other Unusual Items | -479.25K | 83.33K | ||||
| Pretax Income | -7.45M | -3.61M | -12.32M | -11.86M | -10.00M | -9.95M |
| Net Income | -7.45M | -3.61M | -12.32M | -11.86M | -10.00M | -9.95M |
| Net Income to Common | -7.45M | -3.61M | -12.32M | -11.86M | -10.00M | -9.95M |
| Shares Outstanding (Basic) | 8.47M | 6.69M | 4.46M | 3.02M | 2.67M | 1.78M |
| Shares Outstanding (Diluted) | 8.47M | 6.69M | 4.46M | 3.02M | 2.67M | 1.78M |
| EPS (Basic) | -0.88 | -0.54 | -2.76 | -3.93 | -3.75 | -5.58 |
| EPS (Diluted) | -0.95 | -0.54 | -2.76 | -3.93 | -3.75 | -5.58 |
| Free Cash Flow | -7.16M | -2.92M | -11.13M | -13.27M | -7.79M | -8.67M |
| Free Cash Flow Per Share | -0.85 | -0.44 | -2.50 | -4.39 | -2.92 | -4.86 |
| Gross Margin | 23.00% | 26.11% | -115.42% | -147.58% | -143.93% | |
| Operating Margin | -63.36% | -34.94% | -344.26% | -350.84% | -473.14% | -4,205.75% |
| Profit Margin | -59.71% | -29.80% | -356.74% | -348.03% | -471.67% | -4,094.60% |
| Free Cash Flow Margin | -57.44% | -24.13% | -322.39% | -389.45% | -367.67% | -3,568.48% |
| EBITDA | -7.66M | -3.96M | -11.64M | -11.76M | -9.91M | -10.14M |
| EBITDA Margin | -61.46% | -32.77% | ||||
| D&A For EBITDA | 236.88K | 261.68K | 246.79K | 199.27K | 118.62K | 80.75K |
| EBIT | -7.90M | -4.23M | -11.89M | -11.96M | -10.03M | -10.22M |
| EBIT Margin | -63.36% | -34.94% | ||||
| Advertising Expenses | 165.00K | 108.99K | 173.43K | 270.61K | 338.84K |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.05M | 6.57M | 1.46M | 5.32M | 8.16M | 6.90M |
| Short-Term Investments | 2.98M | |||||
| Cash & Short-Term Investments | 2.05M | 6.57M | 1.46M | 5.32M | 11.14M | 6.90M |
| Receivables | 1.10M | 1.26M | 176.64K | 33.24K | 48.34K | |
| Inventory | 2.29M | 2.23M | 2.64M | 1.73M | 704.54K | 98.29K |
| Prepaid Expenses | 318.94K | 141.37K | 216.46K | 263.75K | 296.65K | 151.11K |
| Other Current Assets | 33.05K | 22.92K | 142.63K | 92.93K | ||
| Total Current Assets | 5.79M | 10.23M | 4.63M | 7.31M | 12.18M | 7.29M |
| Property, Plant & Equipment | 369.08K | 514.42K | 671.75K | 694.81K | 534.95K | 512.28K |
| Other Intangible Assets | 28.21K | 44.95K | 67.26K | 89.58K | 111.89K | 134.21K |
| Total Assets | 6.19M | 10.79M | 5.37M | 8.10M | 12.82M | 7.94M |
| Accounts Payable | 905.72K | 1.01M | 1.03M | 685.10K | 927.66K | 528.83K |
| Accrued Expenses | 932.29K | 1.17M | 1.06M | 978.41K | 632.50K | 531.47K |
| Current Portion of Leases | 102.03K | 123.66K | 65.77K | 129.12K | 83.34K | 112.78K |
| Current Unearned Revenue | 1.46M | 8.62K | ||||
| Other Current Liabilities | 101.39K | 1.44K | 59.95K | |||
| Total Current Liabilities | 2.04M | 2.30M | 2.21M | 1.79M | 3.10M | 1.18M |
| Long-Term Leases | 73.32K | 143.15K | 194.39K | 55.28K | 119.56K | 202.90K |
| Other Long-Term Liabilities | 303.81K | 1.27M | 2.14M | |||
| Total Liabilities | 2.42M | 3.71M | 4.55M | 1.85M | 3.22M | 1.38M |
| Common Stock | 8.70K | 50.01K | 30.82K | 23.93K | 16.22K | 12.01K |
| Additional Paid-In Capital | 88.19M | 85.63M | 75.80M | 68.91M | 60.41M | 47.37M |
| Retained Earnings | -84.44M | -78.61M | -75.00M | -62.69M | -50.83M | -40.83M |
| Shareholders' Equity | 3.77M | 7.07M | 822.01K | 6.25M | 9.60M | 6.55M |
| Total Liabilities & Equity | 6.19M | 10.79M | 5.37M | 8.10M | 12.82M | 7.94M |
| Total Debt | 175.34K | 266.81K | 260.16K | 184.40K | 202.90K | 315.67K |
| Net Cash (Debt) | 1.87M | 6.30M | 1.20M | 5.14M | 10.94M | 6.59M |
| Net Cash Per Share | 0.22 | 0.94 | 0.27 | 1.70 | 4.10 | 3.69 |
| Filing Date Shares Outstanding | 9.11M | 8.40M | 5.14M | 3.99M | 2.71M | 2.70M |
| Total Common Shares Outstanding | 8.70M | 8.33M | 5.14M | 3.99M | 2.70M | 2.00M |
| Working Capital | 3.75M | 7.92M | 2.42M | 5.52M | 9.08M | 6.11M |
| Book Value Per Share | 0.43 | 0.85 | 0.16 | 1.57 | 3.55 | 3.27 |
| Tangible Book Value | 3.74M | 7.03M | 754.75K | 6.16M | 9.49M | 6.42M |
| Tangible Book Value Per Share | 0.43 | 0.84 | 0.15 | 1.54 | 3.51 | 3.21 |
| Machinery | 1.16M | 1.06M | 976.30K | 860.74K | 538.06K | 311.49K |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -7.45M | -3.61M | -12.32M | -11.86M | -10.00M | -9.95M |
| Depreciation & Amortization | 236.88K | 261.68K | 246.79K | 199.27K | 118.62K | 80.75K |
| Other Amortization | -192.65K | 3.05K | ||||
| Loss (Gain) From Sale of Assets | 32.14K | |||||
| Loss (Gain) From Sale of Investments | -45.57K | -11.47K | ||||
| Stock-Based Compensation | 1.41M | 1.26M | 1.34M | 1.11M | 947.21K | 1.79M |
| Other Operating Activities | 7.60K | -328.99K | 669.61K | 109.83K | 212.16K | -18.93K |
| Change in Accounts Receivable | -1.10M | -1.09M | -176.64K | 33.24K | 15.10K | -48.34K |
| Change in Inventory | -396.05K | 398.35K | -908.47K | -1.02M | -606.25K | -98.29K |
| Change in Accounts Payable | 433.87K | 239.98K | 66.99K | -247.19K | 515.44K | -350.31K |
| Change in Other Net Operating Assets | -9.95K | 20.65K | 63.50K | -1.19M | 1.29M | -15.80K |
| Operating Cash Flow | -7.05M | -2.84M | -11.01M | -12.89M | -7.52M | -8.60M |
| Capital Expenditures | -109.54K | -81.74K | -120.20K | -384.12K | -275.23K | -67.08K |
| Sale of Property, Plant & Equipment | 7.50K | |||||
| Investment in Securities | 3.03M | -2.97M | ||||
| Investing Cash Flow | -109.54K | -81.74K | -120.20K | 2.65M | -3.24M | -67.08K |
| Issuance of Common Stock | 1.20M | 9.61M | 5.87M | 8.59M | 13.35M | 9.11M |
| Repurchase of Common Stock | -70.36K | -124.62K | -81.40K | -119.42K | ||
| Other Financing Activities | 36.05K | -1.46M | 1.48M | -1.07M | -1.33M | 2.42M |
| Financing Cash Flow | 1.17M | 8.03M | 7.27M | 7.40M | 12.02M | 11.53M |
| Net Cash Flow | -5.99M | 5.11M | -3.86M | -2.84M | 1.26M | 2.86M |
| Free Cash Flow | -7.16M | -2.92M | -11.13M | -13.27M | -7.79M | -8.67M |
| Free Cash Flow Margin | -57.44% | -24.13% | -322.39% | -389.45% | -367.67% | -3,568.48% |
| Free Cash Flow Per Share | -0.85 | -0.44 | -2.50 | -4.39 | -2.92 | -4.86 |
| Levered Free Cash Flow | -4.57M | -1.78M | -6.72M | -8.86M | -4.18M | -5.07M |
| Unlevered Free Cash Flow | -4.37M | -1.65M | -6.65M | -8.86M | -4.18M | -5.07M |
| Change in Working Capital | -1.07M | -429.19K | -954.61K | -2.43M | 1.21M | -512.73K |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.38M | 44.43M | 30.50M | 21.30M | 27.39M | 47.40M |
| Enterprise Value | 6.50M | 36.69M | 29.17M | 18.43M | 17.45M | 38.68M |
| Last Close Price | 0.93 | 5.33 | 5.94 | 5.34 | 10.14 | 23.70 |
| PS Ratio | 0.68 | 3.67 | 8.83 | 6.25 | 12.92 | 195.10 |
| PB Ratio | 2.14 | 6.28 | 37.11 | 3.41 | 2.85 | 7.23 |
| P/TBV Ratio | 2.26 | 6.32 | 40.42 | 3.46 | 2.89 | 7.38 |
| EV/Sales Ratio | 0.53 | 3.03 | 8.45 | 5.41 | 8.23 | 159.21 |
| Debt / Equity Ratio | 0.05 | 0.04 | 0.32 | 0.03 | 0.02 | 0.05 |
| Net Debt / Equity Ratio | -0.50 | -0.89 | -1.46 | -0.82 | -1.14 | -1.00 |
| Net Debt / EBITDA Ratio | 0.24 | 1.59 | 0.10 | 0.44 | 1.10 | 0.65 |
| Net Debt / FCF Ratio | 0.26 | 2.16 | 0.11 | 0.39 | 1.40 | 0.76 |
| Asset Turnover | 1.47 | 1.50 | 0.51 | 0.33 | 0.20 | 0.04 |
| Inventory Turnover | 4.58 | 3.68 | 3.41 | 6.94 | 12.88 | |
| Quick Ratio | 1.54 | 3.40 | 0.74 | 2.97 | 3.61 | 5.88 |
| Current Ratio | 2.84 | 4.44 | 2.09 | 4.08 | 3.93 | 6.17 |
| Return on Equity (ROE) | -124.66% | -91.34% | -348.39% | -149.61% | -123.77% | -230.81% |
| Return on Assets (ROA) | -58.07% | -32.70% | -110.33% | -71.43% | -60.39% | -100.59% |
| Return on Capital Employed (ROCE) | -190.60% | -49.80% | -376.60% | -189.60% | -103.20% | -151.20% |
| Earnings Yield | -103.69% | -8.12% | -40.38% | -55.68% | -36.50% | -20.99% |
| FCF Yield | -84.82% | -6.57% | -36.49% | -62.31% | -28.46% | -18.29% |
| Buyback Yield / Dilution | -44.82% | -50.03% | -47.69% | -13.27% | -49.56% | -97.52% |